Wintrust Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,300
Closed -$207K – 440
2021
Q4
$207K Buy
+1,300
New +$155K 0.02% 403
2021
Q3
– Sell
-1,213
Closed -$202K – 391
2021
Q2
$202K Sell
1,213
-210
-15% -$34K 0.02% 405
2021
Q1
$259K Buy
+1,423
New +$330K 0.03% 352

Other funds holding TDOC

Wintrust Investments's TDOC Position: Q1 2022 in Review

Wintrust Investments sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 1,300 shares — an estimated $207K sold.

Wintrust Investments first reported a position in TDOC in Q1 2021 and held it in 3 quarters. The position peaked at $259K in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Wintrust Investments reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Wintrust Investments sold 1,300 Teladoc Health shares in Q1 2022, an estimated $207K.
  • Wintrust Investments first reported a position in Teladoc Health in Q1 2021 and held it in 3 quarters.
  • Wintrust Investments's Teladoc Health position peaked at $259K in Q1 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Wintrust Investments's 13F filing for Q1 2022, filed 11 May 2022.